Compare CVS Health Corp (CVS) vs T-Rex 2X Long MSTR Daily Target ETF (MSTU) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
CVS Health Corp vs T-Rex 2X Long MSTR Daily Target ETF — how do they compare? CVS Health Corp trades at $93.5 (market cap $122.36B), while T-Rex 2X Long MSTR Daily Target ETF trades at $1.85. The key difference: CVS Health Corp pays a 2.78% dividend while T-Rex 2X Long MSTR Daily Target ETF pays none, and CVS Health Corp is trading nearer its 52-week high, T-Rex 2X Long MSTR Daily Target ETF nearer its low. Which is the better fit depends on your goals.
| CVS | MSTU | |
|---|---|---|
Market Cap | $122.36B | — |
Sector | Health | Leveraged / Inverse |
52-Week High | $110.60 | $76.30 |
52-Week Low | $65.51 | $1.46 |
Enterprise Value | $184.71B | — |
Dividend Yield | 2.78% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CVS Health trades at $95.70, down 0.54% on the day, with a bearish technical signal and key support at $95. The company reported strong Q2 2026 earnings, beating estimates with EPS of $2.58 versus $1.87 expected, and raised its full-year guidance. Revenue growth remains robust, reaching $402.07 billion in 2025, though net income margin compressed to 1.18%. Analyst sentiment is overwhelmingly positive with a consensus price target of $115.00.
The outlook for CVS is cautiously optimistic, driven by operational improvements in its Aetna segment and raised cash flow guidance. Investment opportunities include potential upside to the consensus target, but risks involve margin pressures, regulatory changes impacting pharmacy benefits in 2027, and high debt levels. The stock's current valuation at a P/E of 25.25 may limit near-term gains if earnings growth slows.
MSTU, a leveraged ETF tracking MicroStrategy, trades at $1.995, up 6.4% in 24 hours. Technical indicators show a bullish overall signal but bearish moving averages, with key support and resistance at $2. The stock underwent a 10:1 reverse split on August 24, 2026. Financial ratios are unavailable, and recent news highlights extreme volatility and significant past losses.
Outlook remains highly speculative due to leveraged structure and dependence on MicroStrategy's Bitcoin-heavy strategy. Risks include amplified daily moves and compounding decay. Investor sentiment is cautious amid media reports of steep declines, with no clear fundamental anchor beyond underlying asset performance.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About CVS Health Corp
Following its acquisition of Aetna in late 2018, CVS Health now provides an even more integrated healthcare-services offering for its members. Legacy CVS combined both the largest pharmacy benefit manager, processing over 2 billion adjusted claims annually, and a sizable pharmacy operation, including nearly 10,000 retail pharmacy locations primarily in the U.S. Adding a managed-care organization with 24 million medical members gives the company a strong position in the insurance industry and should help CVS better control overall healthcare costs for its clients.
Read more on CVS →About T-Rex 2X Long MSTR Daily Target ETF
MSTU is a leveraged ETF that seeks daily investment results corresponding to 200% of the daily performance of the MicroStrategy Incorporated (MSTR) stock. It is designed as a tactical tool for experienced traders to take a bullish (long) position in MSTR, a company known for its significant Bitcoin holdings. Due to the effects of compounding and leverage, the ETF is intended to be held for a single day and is not suitable for long-term investment.
Read more on MSTU →
